CN Patent

CN109288790A — 鼻用医药组合物及其制备方法

Assigned to SYNMOSA BIOPHARMA CORP · Expires 2019-02-01 · 7y expired

What this patent protects

本发明提供一种鼻用药物产品或制剂，其中该药物产品或制剂并不包含表面活性剂。

USPTO Abstract

本发明提供一种鼻用药物产品或制剂，其中该药物产品或制剂并不包含表面活性剂。

Drugs covered by this patent

azelastine-hydrochloride (AZELASTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN109288790A
Jurisdiction: CN
Classification: —
Expires: 2019-02-01
Drug substance claim: No
Drug product claim: No
Assignee: SYNMOSA BIOPHARMA CORP
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.